MD Clone has raised $26 million, in a new funding round. Leading the new investment is the aMoon fund of Mauris Nacht, one of Check Point’s founders. Also participating were the current investors OrbiMed and Lightspeed Venture Partners. MD Clone has developed a unique method of anonymizing patient data at hospitals, then allowing researchers to use the anonymous data to conduct research. Most of the company’s 50 current employees are located in Beersheva. With the new round of financing, Rada will increase its staffing. This round brings the amount raised by Rada to $41 million, since the founding of the company in 2016.
